Neuphoria Therapeutics Inc.
NEUP · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$370 | -$15 | -$14 | -$15 |
| Dep. & Amort. | $663 | $1 | $0 | $1 |
| Deferred Tax | -$468 | $0 | $0 | $0 |
| Stock-Based Comp. | $164 | $1 | $0 | $2 |
| Change in WC | -$0 | $1 | $3 | -$4 |
| Other Non-Cash | $89 | -$2 | $1 | $1 |
| Operating Cash Flow | $77 | -$15 | -$10 | -$15 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$0 |
| Stock Issued | $2 | $10 | $3 | $23 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,527 | $5 | $0 | -$4 |
| Financing Cash Flow | $1,528 | $15 | $3 | $19 |
| Forex Effect | -$4 | $0 | -$8 | -$1 |
| Net Chg. in Cash | $1,602 | $1 | -$15 | $3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,687 | $12 | $23 | $20 |
| End Cash | $14,289 | $13 | $8 | $23 |
| Free Cash Flow | $77 | -$15 | -$10 | -$15 |